Trials / Completed
CompletedNCT00634959
Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus
An Investigation Into The Effects Of Food And Dose Regimen On Viral Load Response In HIV Infected Patients On Short-Term Monotherapy With UK-427,857 (Maraviroc)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the effects of food and dose regimen on the antiviral effects of Maraviroc (UK-427,857) in patients with human immunodeficiency virus (HIV)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Maraviroc (UK-427,857) | 150 mg oral tablet twice daily while fasted on Days 1-9 and on Day 10 (morning dose only) |
| DRUG | Maraviroc (UK-427,857) | 100 mg oral tablet once daily while fasted on Days 1-10 |
| DRUG | Maraviroc (UK-427,857) | 300 mg oral tablet once daily while fasted on Days 1-10 |
| DRUG | Maraviroc (UK-427,857) | 150 mg oral tablet twice daily with food on Days 1-9 and on Day 10 (morning dose only) |
| OTHER | Placebo | Matching placebo oral tablet on Days 1-10 (fed and fasted) |
Timeline
- Start date
- 2003-07-01
- Completion
- 2003-12-01
- First posted
- 2008-03-13
- Last updated
- 2010-11-10
Locations
7 sites across 3 countries: United States, Germany, United Kingdom
Source: ClinicalTrials.gov record NCT00634959. Inclusion in this directory is not an endorsement.